Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 5
2004 2
2005 5
2006 6
2007 4
2008 10
2009 11
2010 11
2011 12
2012 12
2013 13
2014 13
2015 17
2016 16
2017 17
2018 18
2019 15
2020 39
2021 33
2022 37
2023 41
2024 53
2025 45
2026 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

377 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.
Male C, Lensing AWA, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bonnet D, Connor P, Hooimeijer HL, Torres M, Chan AKC, Kenet G, Holzhauer S, Santamaría A, Amedro P, Chalmers E, Simioni P, Bhat RV, Yee DL, Lvova O, Beyer-Westendorf J, Biss TT, Martinelli I, Saracco P, Peters M, Kállay K, Gauger CA, Massicotte MP, Young G, Pap AF, Majumder M, Smith WT, Heubach JF, Berkowitz SD, Thelen K, Kubitza D, Crowther M, Prins MH, Monagle P; EINSTEIN-Jr Phase 3 Investigators. Male C, et al. Among authors: simioni p. Lancet Haematol. 2020 Jan;7(1):e18-e27. doi: 10.1016/S2352-3026(19)30219-4. Epub 2019 Nov 5. Lancet Haematol. 2020. PMID: 31699660 Free article. Clinical Trial.
Portal Vein Thrombosis: State-of-the-Art Review.
Boccatonda A, Gentilini S, Zanata E, Simion C, Serra C, Simioni P, Piscaglia F, Campello E, Ageno W. Boccatonda A, et al. Among authors: simioni p. J Clin Med. 2024 Mar 6;13(5):1517. doi: 10.3390/jcm13051517. J Clin Med. 2024. PMID: 38592411 Free PMC article. Review.
Thrombophilia, risk factors and prevention.
Campello E, Spiezia L, Adamo A, Simioni P. Campello E, et al. Among authors: simioni p. Expert Rev Hematol. 2019 Mar;12(3):147-158. doi: 10.1080/17474086.2019.1583555. Epub 2019 Feb 26. Expert Rev Hematol. 2019. PMID: 30773075 Review.
Asundexian versus Apixaban in Patients with Atrial Fibrillation.
Piccini JP, Patel MR, Steffel J, Ferdinand K, Van Gelder IC, Russo AM, Ma CS, Goodman SG, Oldgren J, Hammett C, Lopes RD, Akao M, De Caterina R, Kirchhof P, Gorog DA, Hemels M, Rienstra M, Jones WS, Harrington J, Lip GYH, Ellis SJ, Rockhold FW, Neumann C, Alexander JH, Viethen T, Hung J, Coppolecchia R, Mundl H, Caso V; OCEANIC-AF Steering Committee and Investigators. Piccini JP, et al. N Engl J Med. 2025 Jan 2;392(1):23-32. doi: 10.1056/NEJMoa2407105. Epub 2024 Sep 1. N Engl J Med. 2025. PMID: 39225267 Clinical Trial.
Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT).
Connor P, Sánchez van Kammen M, Lensing AWA, Chalmers E, Kállay K, Hege K, Simioni P, Biss T, Bajolle F, Bonnet D, Grunt S, Kumar R, Lvova O, Bhat R, Van Damme A, Palumbo J, Santamaria A, Saracco P, Payne J, Baird S, Godder K, Labarque V, Male C, Martinelli I, Morales Soto M, Motwani J, Shah S, Hooimeijer HL, Prins MH, Kubitza D, Smith WT, Berkowitz SD, Pap AF, Majumder M, Monagle P, Coutinho JM. Connor P, et al. Among authors: simioni p. Blood Adv. 2020 Dec 22;4(24):6250-6258. doi: 10.1182/bloodadvances.2020003244. Blood Adv. 2020. PMID: 33351120 Free PMC article. Clinical Trial.
COL4A1 and COL4A2-related disorders: Clinical features, diagnostic guidelines, and management.
Tambala D, Vassar R, Snow J, Balestrini S, Bersano A, Guey S, Bonaventura E, Signorini S, Sartori S, Bertini E, Tonduti D, Parazzini C, Macchiaiolo M, Pelizza MF, Pichiecchio A, Massella L, Coste T, Orcesi S, Politano D, Bacci G, Marziali E, Dollfus H, Mandelli A, Chinali M, Plaisier E, Simioni P, Colombatti R, Guerrini R, Tournier-Lasserve E, Gould DB, Musolino PL. Tambala D, et al. Among authors: simioni p. Genet Med. 2025 Sep;27(9):101514. doi: 10.1016/j.gim.2025.101514. Epub 2025 Jul 2. Genet Med. 2025. PMID: 40616396 Free article.
FVIII half-life products: A real-world experience.
Zanon E, Porreca A, Napolitano A, Simion C, Simioni P. Zanon E, et al. Among authors: simioni p. Thromb Res. 2025 May;249:109306. doi: 10.1016/j.thromres.2025.109306. Epub 2025 Mar 14. Thromb Res. 2025. PMID: 40147314
Possible role of bone turnover markers in the diagnosis of adult hypophosphatasia.
Bertoldo F, Tripepi G, Zaninotto M, Plebani M, Scillitani A, Varenna M, Crotti C, Cipriani C, Pepe J, Minisola S, Pugliese F, Guarnieri V, Baffa V, Torres MO, Zanchetta F, Fusaro M, Rossini M, Brandi ML, Egan CG, Simioni P, Arcidiacono GP, Sella S, Giannini S. Bertoldo F, et al. Among authors: simioni p. J Bone Miner Res. 2024 Dec 31;40(1):79-86. doi: 10.1093/jbmr/zjae177. J Bone Miner Res. 2024. PMID: 39498489 Free PMC article.
Real-world data from a national survey on management of CKD-associated osteoporosis among Italian nephrologists.
Fusaro M, Cossettini A, Re Sartò GV, Aghi A, Mereu MC, Gallieni M, Cosmai L, Bellasi A, Alfieri CM, Cejka D, McCloskey E, Cavalier E, Harvey NC, Nickolas TL, Brandi ML, Ferrari S, Marino C, Giannini S, Sella S, Arcidiacono GP, Simioni P, Plebani M, Zaninotto M, De Nicola L, Marcantoni C, de Borst MH, Ravera M, Frediani B, Bover J, Lafage-Proust MH, Reginster JY, Bertoldo F, Tripepi G, Haarhaus M; An initiative and on behalf of the CKD-MBD working group the European Renal Association and the Committee of Scientific Advisors and National Societies of the IOF. Fusaro M, et al. Among authors: simioni p. Arch Osteoporos. 2025 Jul 16;20(1):96. doi: 10.1007/s11657-025-01570-z. Arch Osteoporos. 2025. PMID: 40668510 Free article.
377 results